239 related articles for article (PubMed ID: 10458765)
1. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope.
Quarsten H; Molberg O; Fugger L; McAdam SN; Sollid LM
Eur J Immunol; 1999 Aug; 29(8):2506-14. PubMed ID: 10458765
[TBL] [Abstract][Full Text] [Related]
2. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation.
Qiao SW; Bergseng E; Molberg O; Jung G; Fleckenstein B; Sollid LM
J Immunol; 2005 Jul; 175(1):254-61. PubMed ID: 15972656
[TBL] [Abstract][Full Text] [Related]
3. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
[TBL] [Abstract][Full Text] [Related]
4. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
[TBL] [Abstract][Full Text] [Related]
5. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
Anderson RP; Degano P; Godkin AJ; Jewell DP; Hill AV
Nat Med; 2000 Mar; 6(3):337-42. PubMed ID: 10700238
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
Qiao SW; Bergseng E; Molberg Ø; Xia J; Fleckenstein B; Khosla C; Sollid LM
J Immunol; 2004 Aug; 173(3):1757-62. PubMed ID: 15265905
[TBL] [Abstract][Full Text] [Related]
7. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
[TBL] [Abstract][Full Text] [Related]
8. Human genome search in celiac disease: mutated gliadin T-cell-like epitope in two human proteins promotes T-cell activation.
Kumar R; Eastwood AL; Brown ML; Laurie GW
J Mol Biol; 2002 Jun; 319(3):593-602. PubMed ID: 12054857
[TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
Molberg O; Mcadam SN; Körner R; Quarsten H; Kristiansen C; Madsen L; Fugger L; Scott H; Norén O; Roepstorff P; Lundin KE; Sjöström H; Sollid LM
Nat Med; 1998 Jun; 4(6):713-7. PubMed ID: 9623982
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.
Tollefsen S; Arentz-Hansen H; Fleckenstein B; Molberg O; Ráki M; Kwok WW; Jung G; Lundin KE; Sollid LM
J Clin Invest; 2006 Aug; 116(8):2226-36. PubMed ID: 16878175
[TBL] [Abstract][Full Text] [Related]
11. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition.
Sjöström H; Lundin KE; Molberg O; Körner R; McAdam SN; Anthonsen D; Quarsten H; Norén O; Roepstorff P; Thorsby E; Sollid LM
Scand J Immunol; 1998 Aug; 48(2):111-5. PubMed ID: 9716100
[TBL] [Abstract][Full Text] [Related]
12. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.
Arentz-Hansen H; McAdam SN; Molberg Ø; Fleckenstein B; Lundin KE; Jørgensen TJ; Jung G; Roepstorff P; Sollid LM
Gastroenterology; 2002 Sep; 123(3):803-9. PubMed ID: 12198706
[TBL] [Abstract][Full Text] [Related]
13. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
14. Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.
Huan J; Meza-Romero R; Mooney JL; Vandenbark AA; Offner H; Burrows GG
Mucosal Immunol; 2011 Jan; 4(1):112-20. PubMed ID: 20736999
[TBL] [Abstract][Full Text] [Related]
15. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
Costantini S; Rossi M; Colonna G; Facchiano AM
J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
[TBL] [Abstract][Full Text] [Related]
16. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
[TBL] [Abstract][Full Text] [Related]
17. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
18. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays.
Johansen BH; Gjertsen HA; Vartdal F; Buus S; Thorsby E; Lundin KE; Sollid LM
Clin Immunol Immunopathol; 1996 Jun; 79(3):288-93. PubMed ID: 8635288
[TBL] [Abstract][Full Text] [Related]
19. Design of gliadin peptide analogues with low affinity for the celiac disease associated HLA-DQ2 protein.
Fraccalvieri D; Motta S; Galliani G; Cavaletti L; Bonati L
Mol Biosyst; 2014 Aug; 10(8):2064-73. PubMed ID: 24841193
[TBL] [Abstract][Full Text] [Related]
20. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.
Aleanzi M; Demonte AM; Esper C; Garcilazo S; Waggener M
Clin Chem; 2001 Nov; 47(11):2023-8. PubMed ID: 11673371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
